Primary Catalyst Driving Immunoglobulins Market Evolution in 2025: Growing Geriatric Population Fuels Demand For Immunoglobulins Market Driver

How Are the key drivers contributing to the expansion of the immunoglobulins market?
The escalating number of elderly individuals is fueling the expansion of the immunoglobulins market. This group of the population is highly susceptible to infections and autoimmune diseases. The immunoglobulin examination gauges the ability of the human body to generate antibodies responsible for defending itself against bacteria, viruses, and allergies. For example, a report issued in October 2022 by the World Health Organization (WHO), an agency based in Switzerland that oversees global public health, predicted that one in every six people will be 60 or older by 2030 globally. By 2050, it's attributable to reach 2.1 billion people across the globe who are of age 60 and above. Consequently, the growth in the elderly population is anticipated to bolster the demand for the immunoglobulins market in the upcoming years.

Get Your Immunoglobulins Market Report Here:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

What growth opportunities are expected to drive the immunoglobulins market's CAGR through 2034?
The market for immunoglobulins has seen robust expansion in the past years. It is projected to escalate from a value of $18.85 billion in 2024 to reach $20.53 billion in 2025, marking a compound annual growth rate (CAGR) of 8.9%. Factors contributing to growth during the historical phase include the increasing incidence of immunodeficiency disorders, the expanding aged population, rising implementation of immunoglobulins in healthcare facilities, supportive government reimbursement policies, and the growing prevalence of chronic and autoimmune diseases.

In the coming years, the immunoglobulins market is forecasted to experience a significant expansion, growing to a value of $31.59 billion by 2029 with a compound annual growth rate (CAGR) of 11.4%. This forecasted growth can be linked to several key factors such as the increase in investment towards the creation of novel technologies, rising awareness of immunodeficiency therapies, the preference for these therapies by physicians, the advent of new markets, and broadening of its applications in the field of sports and fitness. Notable trends for this period consist of the production of wearable and smart compression devices, tailored compression therapy solutions, incorporation of compression therapy into wound care management, focus on patient comfort and conformity in compression therapy, as well as enhanced cooperation between manufacturers and healthcare providers for improved patient results.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What are the emerging trends shaping the future of the immunoglobulins market?
In an effort to further cater to a growing customer base and boost their sales and revenue, key companies in the immunoglobulins market are focusing on creating innovative products such as intravenous immunoglobulins. For example, in September 2024, GC Biopharma, a biotech company based in South Korea, introduced its product, ALYGLOTM (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market. This product targets the treatment of primary humoral immunodeficiency (PI) in adults who are 17 years or older and is now accessible to patients via specialty pharmacies. The release is especially significant considering the U.S. is the world's largest immunoglobulin market, estimated at approximately $11.6 billion. GC Biopharma has set a target of generating $50 million in sales from ALYGLO in its debut year and plans to up this amount to $300 million by 2028. In order to effectively distribute immunoglobulin products, the company's ambitious growth strategy involves forging partnerships with leading U.S. pharmacy benefit managers and specialty pharmacies.

Which growth-oriented segments of the immunoglobulins market are leading the industry's development?
The immunoglobulins market covered in this report is segmented -

1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:
1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5284

What regions are leading the charge in the immunoglobulins market?
North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the immunoglobulins market?
Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What Is Covered In The Immunoglobulins Global Market Report?

•Market Size Forecast: Examine the immunoglobulins market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the immunoglobulins market for a structured understanding.
•Key Players Overview: Analyze major players in the immunoglobulins market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the immunoglobulins market.
•Segment Contributions: Evaluate how different segments drive overall growth in the immunoglobulins market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the immunoglobulins market.
•Industry Challenges: Identify potential risks and obstacles affecting the immunoglobulins market.
•Competitive Landscape: Review strategic developments in the immunoglobulins market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.